3rd Quarter - Report

THE MCMANUS GROUP for EMD SERONO, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Provisions included in Subtitle J - Drug Pricing of H.R. 5376 - Build Back Better Act.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Health Issues HCR

General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME LD, Rep. Jon Porter

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.